Description
Orencia is a selective co-stimulation modulator that is indicated for the treatment of moderate to severely active rheumatoid arthritis in adults, moderate to severely active polyarticular juvenile idiopathic arthritis in patients aged two and older, and psoriatic arthritis in adults. Its active ingredient, abatacept, is a fusion protein designed to stop T-cell activation, thereby preventing its immune activity.
